Biosimilar Monoclonal Antibody Market - Forecast(2024 - 2030)

Report Code: HCR 87432 Report Format: PDF + Excel
1. Biosimilar Monoclonal Antibody Market - Overview
        1.1 Definitions and Scope
2. Biosimilar Monoclonal Antibody Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Biosimilar Monoclonal Antibody Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Biosimilar Monoclonal Antibody Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Biosimilar Monoclonal Antibody Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Biosimilar Monoclonal Antibody Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Biosimilar Monoclonal Antibody Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Biosimilar Monoclonal Antibody Market - By Type (Market Size -$Million / $Billion)
        8.1 Market Size and Market Share Analysis
        8.2 Application Revenue and Trend Research
        8.3 Segment Analysis
            8.3.1 Synthetic Chemical
            8.3.2 Biopharmaceuticals
9. Biosimilar Monoclonal Antibody Market - By Product (Market Size -$Million / $Billion)
10. Biosimilar Monoclonal Antibody - By Application (Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
            10.3.1 Chronic Autoimmune Disease
            10.3.2 Oncology
11. Biosimilar Monoclonal Antibody- By Geography (Market Size -$Million / $Billion)
        11.1 Biosimilar Monoclonal Antibody Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Biosimilar Monoclonal Antibody- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Biosimilar Monoclonal Antibody- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Biosimilar Monoclonal Antibody - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 Biosimilar Monoclonal Antibody - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Biosimilar Monoclonal Antibody Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Biosimilar Monoclonal Antibody Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Biosimilar Monoclonal Antibody Market - Key Company List by Country Premium
15. Biosimilar Monoclonal Antibody Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 3Sbio
        15.3 Accord Healthcare
        15.4 Aet Biotech
        15.5 Allergan
        15.6 Alvartis Pharma
        15.7 Amgen
        15.8 Biocon
        15.9 Celltrion
        15.10 Dr. Reddy'S Laboratory
        15.11 Hospira
        15.12 Company 12
        15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Biosimilar Monoclonal Antibody Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Biosimilar Monoclonal Antibody Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Biosimilar Monoclonal Antibody Market, By Type Market 2023-2030 ($M)
1.1 Synthetic Chemical Market 2023-2030 ($M) - Global Industry Research
1.2 Biopharmaceuticals Market 2023-2030 ($M) - Global Industry Research
2.Global Biosimilar Monoclonal Antibody Market, By Type Market 2023-2030 (Volume/Units)
2.1 Synthetic Chemical Market 2023-2030 (Volume/Units) - Global Industry Research
2.2 Biopharmaceuticals Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America Biosimilar Monoclonal Antibody Market, By Type Market 2023-2030 ($M)
3.1 Synthetic Chemical Market 2023-2030 ($M) - Regional Industry Research
3.2 Biopharmaceuticals Market 2023-2030 ($M) - Regional Industry Research
4.South America Biosimilar Monoclonal Antibody Market, By Type Market 2023-2030 ($M)
4.1 Synthetic Chemical Market 2023-2030 ($M) - Regional Industry Research
4.2 Biopharmaceuticals Market 2023-2030 ($M) - Regional Industry Research
5.Europe Biosimilar Monoclonal Antibody Market, By Type Market 2023-2030 ($M)
5.1 Synthetic Chemical Market 2023-2030 ($M) - Regional Industry Research
5.2 Biopharmaceuticals Market 2023-2030 ($M) - Regional Industry Research
6.APAC Biosimilar Monoclonal Antibody Market, By Type Market 2023-2030 ($M)
6.1 Synthetic Chemical Market 2023-2030 ($M) - Regional Industry Research
6.2 Biopharmaceuticals Market 2023-2030 ($M) - Regional Industry Research
7.MENA Biosimilar Monoclonal Antibody Market, By Type Market 2023-2030 ($M)
7.1 Synthetic Chemical Market 2023-2030 ($M) - Regional Industry Research
7.2 Biopharmaceuticals Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
2.Canada Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
3.Mexico Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
4.Brazil Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
5.Argentina Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
6.Peru Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
7.Colombia Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
8.Chile Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
9.Rest of South America Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
10.UK Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
11.Germany Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
12.France Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
13.Italy Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
14.Spain Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
15.Rest of Europe Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
16.China Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
17.India Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
18.Japan Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
19.South Korea Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
20.South Africa Biosimilar Monoclonal Antibody Market Revenue, 2023-2030 ($M)
21.North America Biosimilar Monoclonal Antibody By Application
22.South America Biosimilar Monoclonal Antibody By Application
23.Europe Biosimilar Monoclonal Antibody By Application
24.APAC Biosimilar Monoclonal Antibody By Application
25.MENA Biosimilar Monoclonal Antibody By Application
26.Biocon, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Accord Healthcare, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Aet Biotech, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Amgen, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Celltrion, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Dr. Reddy'S Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Hospira, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.3Sbio, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Allergan, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Alvartis Pharma, Sales /Revenue, 2015-2018 ($Mn/$Bn)